-
Entity
-
Individual
-
Location
-
C/O Aerie Pharmaceuticals, Inc., 4301 Emperor Blvd., Suite 400, Durham, North Carolina
-
Summary
-
The estimated net worth of David Hollander is at least $1.28 M dollars as of July 3, 2024. David Hollander is the CMO & Global Therapeutics Lead of Revance Therapeutics, Inc. and owns shares of Revance Therapeutics, Inc. (RVNC) stock worth about $813 K. David Hollander is the Chief R&D Officer of AERIE PHARMACEUTICALS INC and owns shares of AERIE PHARMACEUTICALS INC stock worth about $469 K.